TFC Therapeutics
Transforming T cells into medicines
New York, United States · Founded 2022 · $100K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- tfctx.com
- Total Funding
- $100K
- Last Round
- $100K SeedMar 2026
- Rounds
- 2
About
TFC Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based immunotherapies for cancer and autoimmune diseases, leveraging a proprietary TFC platform.
Summary
TFC Therapeutics is a Biotech company based in New York, United States, founded in 2022. It has raised $100K in total across 2 rounds, most recently a $100K Seed round in Mar 2026. Investors include ARCH Venture Partners, Alumni Ventures and Breakout Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2026
Sign up to see all 2 rounds
Seed — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tfc-therapeutics"><img src="https://indexed.vc/api/badge/company/tfc-therapeutics" alt="TFC Therapeutics on Indexed.vc" width="260" height="76" /></a>